Literature DB >> 17570972

Leishmania tropica infection, in comparison to Leishmania major, induces lower delayed type hypersensitivity in BALB/c mice.

Hamid Mahmoudzadeh-Niknam1, Simin Sadat Kiaei, Davood Iravani.   

Abstract

Leishmania tropica and L. major are etiologic agents of human cutaneous leishmaniasis. Delayed type hypersensitivity (DTH) is an immunologic response that has been frequently used as a correlate for protection against or sensitization to leishmania antigen. In BALB/c mice, L. tropica infection results in non-ulcerating disease, whereas L. major infection results in destructive lesions. In order to clarify the immunologic mechanisms of these 2 different outcomes, we compared the ability of these 2 leishmania species in induction of DTH response in this murine model. BALB/c mice were infected with L. major or L. tropica, and disease evolution and DTH responses were determined. The results show that the primary L. major infection can exacerbate the secondary L. major infection and is associated with DTH response. Higher doses of the primary L. major infection result in more disease exacerbation of the secondary L. major infection as well as higher DTH response. L. tropica infection induces lower DTH responses than L. major. We have previously reported that the primary L. tropica infection induces partial protection against the secondary L. major infection in BALB/c mice. Induction of lower DTH response by L. tropica suggests that the protection induced against L. major by prior L. tropica infection may be due to suppression of DTH response.

Entities:  

Mesh:

Year:  2007        PMID: 17570972      PMCID: PMC2526302          DOI: 10.3347/kjp.2007.45.2.103

Source DB:  PubMed          Journal:  Korean J Parasitol        ISSN: 0023-4001            Impact factor:   1.341


  15 in total

1.  CD28 costimulation and parasite dose combine to influence the susceptibility of BALB/c mice to infection with Leishmania major.

Authors:  Helen L Compton; Jay P Farrell
Journal:  J Immunol       Date:  2002-02-01       Impact factor: 5.422

2.  Mast cells at the host-pathogen interface: host-protection versus immune evasion in leishmaniasis.

Authors:  B Saha; A M D J Tonkal; S Croft; S Roy
Journal:  Clin Exp Immunol       Date:  2004-07       Impact factor: 4.330

3.  Inbred strains derived from feral mice reveal new pathogenic mechanisms of experimental leishmaniasis due to Leishmania major.

Authors:  Besma E C Babay; Hechmi Louzir; Chahnaz Kebaïer; Samir Boubaker; Koussay Dellagi; Pierre-André Cazenave
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

4.  Induction of delayed-type hypersensitivity to Leishmania major and the concomitant acceleration of disease development in progressive murine cutaneous leishmaniasis.

Authors:  J S Dhaliwal; F Y Liew
Journal:  Infect Immun       Date:  1987-03       Impact factor: 3.441

5.  Specific suppressor T cells for delayed-type hypersensitivity in susceptible mice immunized against cutaneous leishmaniasis.

Authors:  J S Dhaliwal; F Y Liew; F E Cox
Journal:  Infect Immun       Date:  1985-08       Impact factor: 3.441

6.  Prophylactic immunization against experimental leishmaniasis. V. Mechanism of the anti-protective blocking effect induced by subcutaneous immunization against Leishmania major infection.

Authors:  F Y Liew; A Singleton; E Cillari; J G Howard
Journal:  J Immunol       Date:  1985-09       Impact factor: 5.422

7.  Leishmania tropica: cysteine proteases are essential for growth and pathogenicity.

Authors:  H Mahmoudzadeh-Niknam; J H McKerrow
Journal:  Exp Parasitol       Date:  2004 Mar-Apr       Impact factor: 2.011

8.  The correlation between delayed hypersensitivity, lymphocyte activation and protective immunity in experimental murine leishmaniasis.

Authors:  R A De Rossell; R S Bray; J Alexander
Journal:  Parasite Immunol       Date:  1987-01       Impact factor: 2.280

9.  Leishmania tropica: the identification and purification of metacyclic promastigotes and use in establishing mouse and hamster models of cutaneous and visceral disease.

Authors:  R Lira; S Méndez; L Carrera; C Jaffe; F Neva; D Sacks
Journal:  Exp Parasitol       Date:  1998-07       Impact factor: 2.011

10.  Immunological regulation of experimental cutaneous leishmaniasis. III. Nature and significance of specific suppression of cell-mediated immunity in mice highly susceptible to Leishmania tropica.

Authors:  J G Howard; C Hale; F Y Liew
Journal:  J Exp Med       Date:  1980-09-01       Impact factor: 14.307

View more
  5 in total

1.  Viscerotropic growth pattern of Leishmania tropica in BALB/c mice is suggestive of a murine model for human viscerotropic leishmaniasis.

Authors:  Hamid Mahmoudzadeh-Niknam; Simin Sadat Kiaei; Davood Iravani
Journal:  Korean J Parasitol       Date:  2007-12       Impact factor: 1.341

2.  Antineoplastic drug, carboplatin, protects mice against visceral leishmaniasis.

Authors:  Tejinder Kaur; Prerna Makkar; Kulbir Randhawa; Sukhbir Kaur
Journal:  Parasitol Res       Date:  2012-09-09       Impact factor: 2.289

3.  The route of Leishmania tropica infection determines disease outcome and protection against Leishmania major in BALB/c mice.

Authors:  Hamid Mahmoudzadeh-Niknam; Ghader Khalili; Firoozeh Abrishami; Ali Najafy; Vahid Khaze
Journal:  Korean J Parasitol       Date:  2013-02-18       Impact factor: 1.341

Review 4.  A Review: The Current In Vivo Models for the Discovery and Utility of New Anti-leishmanial Drugs Targeting Cutaneous Leishmaniasis.

Authors:  Emily Rose Mears; Farrokh Modabber; Robert Don; George E Johnson
Journal:  PLoS Negl Trop Dis       Date:  2015-09-03

5.  Vaccination with whole-cell killed or recombinant leishmanial protein and toll-like receptor agonists against Leishmania tropica in BALB/c mice.

Authors:  Mosayeb Rostamian; Fariborz Bahrami; Hamid M Niknam
Journal:  PLoS One       Date:  2018-09-24       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.